Simplify Asset Management Inc.
Reported holdings as of Q3 2026, from 24 quarterly filings.
Holdings
Download these holdings as CSV
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| SIMPLIFY EXCHANGE TRADED FUN | SBIL | $4.0B | 39,748,238 | -3.31pp | 5q | -19.1%-$939.9M | |
| ISHARES TR | IVV | $780.1M | 1,018,592 | +1.91pp | 24q | -2.3%-$18.4M | |
| ISHARES TR | AGG | $445.3M | 4,710,059 | +0.35pp | 19q | -6.6%-$31.4M | |
| ISHARES BITCOIN TRUST ETF CALL+PUT | IBIT | $147.7M | 357,300 | +1.52pp | 6q | -26.6%-$53.6M | |
| SPDR GOLD TR CALL | GLD | $89.5M | options only | +0.90pp | 2q | OPTIONS | |
| SIMPLIFY EXCHANGE TRADED FUN | QIS | $48.1M | 4,477,620 | +0.26pp | 12q | +18.5%+$7.5M | |
| SIMPLIFY EXCHANGE TRADED FUN | CTAP | $44.0M | 1,500,000 | +0.68pp | 4q | +1400.0%+$41.1M | |
| SIMPLIFY EXCHANGE TRADED FUN | NMB | $35.9M | 1,553,376 | +0.05pp | 9q | HELD | |
| ELI LILLY & CO | LLY | $34.8M | 30,088 | +0.32pp | 20q | +104.5%+$17.8M | |
| PLAINS GP HLDGS L P | PAGP | $33.0M | 1,272,360 | +0.11pp | 15q | HELD | |
| SIMPLIFY EXCHANGE TRADED FUN | XV | $27.7M | 1,149,406 | +0.24pp | 6q | +84.1%+$12.7M | |
| SIMPLIFY EXCHANGE TRADED FUN | SPUC | $27.2M | 559,812 | -0.67pp | 7q | -65.8%-$52.1M | |
| HUMANA INC | HUM | $24.9M | 65,190 | - | new | NEW | |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | $22.9M | 865,862 | - | new | NEW | |
| SIMPLIFY EXCHANGE TRADED FUN | BUCK | $22.5M | 975,000 | -0.19pp | 3q | -42.6%-$16.7M | |
| WARBY PARKER INC | WRBY | $17.4M | 627,337 | +0.04pp | 4q | +6.9%+$1.1M | |
| ABBVIE INC | ABBV | $16.8M | 64,262 | +0.05pp | 7q | HELD | |
| JOHNSON & JOHNSON | JNJ | $16.5M | 62,457 | +0.01pp | 20q | -14.3%-$2.8M | |
| THERMO FISHER SCIENTIFIC INC | TMO | $16.3M | 24,130 | +0.11pp | 20q | +4.6%+$709.5K | |
| UNITEDHEALTH GROUP INC | UNH | $15.2M | 41,403 | flat | 20q | -1.9%-$297.0K | |
| PURECYCLE TECHNOLOGIES INC | PCT | $14.7M | 3,326,255 | -0.10pp | 15q | +9.1%+$1.2M | |
| AVANTOR INC | AVTR | $14.5M | 965,919 | - | new | NEW | |
| Jazz Pharmaceuticals PLC | JAZZ | $12.5M | 53,790 | -0.03pp | 4q | -21.5%-$3.4M | |
| SIMPLIFY EXCHANGE TRADED FUN | AGGH | $12.3M | 651,127 | -0.39pp | 17q | -69.1%-$27.6M | |
| GILEAD SCIENCES INC | GILD | $12.1M | 81,061 | +0.05pp | 9q | HELD | |
| QUEST DIAGNOSTICS INC | DGX | $11.5M | 49,538 | +0.04pp | 2q | HELD | |
| BENITEC BIOPHARMA INC | BNTC | $10.0M | 1,002,201 | -0.02pp | 10q | HELD | |
| SIMPLIFY EXCHANGE TRADED FUN | CAS | $10.0M | 428,078 | -0.01pp | 2q | HELD | |
| AMGEN INC | AMGN | $8.8M | 20,917 | +0.04pp | 4q | HELD | |
| GUARDANT HEALTH INC | GH | $8.7M | 48,940 | +0.09pp | 6q | +77.5%+$3.8M | |
| UNITED THERAPEUTICS CORP DEL | UTHR | $8.7M | 16,084 | -0.20pp | 5q | -64.6%-$15.9M | |
| SUMMIT THERAPEUTICS INC | SMMT | $8.6M | 510,106 | - | new | NEW | |
| ACHIEVE LIFE SCIENCE INC | ACHV | $7.5M | 932,105 | -0.01pp | 11q | -34.9%-$4.0M | |
| BIOHAVEN LTD | BHVN | $7.4M | 550,693 | -0.10pp | 6q | -47.1%-$6.5M | |
| 10X GENOMICS INC | TXG | $6.2M | 68,239 | -0.06pp | 4q | -76.7%-$20.3M | |
| GRAIL INC | GRAL | $6.0M | 42,969 | - | new | NEW | |
| CVS HEALTH CORP | CVS | $6.0M | 69,933 | flat | 8q | -1.6%-$99.1K | |
| CARDINAL HEALTH INC | CAH | $6.0M | 26,830 | +0.01pp | 2q | HELD | |
| VERTEX PHARMACEUTICALS INC | VRTX | $5.5M | 10,428 | +0.02pp | 8q | HELD | |
| VANECK BITCOIN ETF | HODL | $4.2M | 175,843 | +0.01pp | 7q | -33.5%-$2.1M | |
| ESTABLISHMENT LABS HLDGS INC | ESTA | $3.9M | 60,333 | -0.01pp | 5q | HELD | |
| DELCATH SYS INC | DCTH | $3.6M | 227,679 | +0.01pp | 8q | -14.0%-$592.3K | |
| TESLA INC | TSLA | $3.6M | 10,165 | flat | 24q | -4.3%-$161.8K | |
| SIMPLIFY EXCHANGE TRADED FUN | NXTI | $3.5M | 97,303 | -0.34pp | 10q | -88.2%-$26.0M | |
| GE HEALTHCARE TECHNOLOGIES I | GEHC | $3.4M | 51,877 | +0.01pp | 6q | HELD | |
| SCHEIN HENRY INC | HSIC | $3.2M | 37,999 | - | new | NEW | |
| SIMPLIFY EXCHANGE TRADED FUN | LITL | $3.0M | 91,464 | +0.01pp | 6q | HELD | |
| MILESTONE PHARMACEUTICALS IN | MIST | $2.9M | 3,349,379 | -0.01pp | 7q | HELD | |
| ELEVANCE HEALTH INC FORMERLY | ELV | $2.8M | 7,316 | -0.09pp | 2q | -71.4%-$7.1M | |
| SIMPLIFY EXCHANGE TRADED FUN | XXV | $2.7M | 116,500 | +0.01pp | 4q | HELD | |
| CORCEPT THERAPEUTICS INC | CORT | $2.4M | 20,568 | +0.01pp | 3q | -22.2%-$675.9K | |
| RITHM CAPITAL CORP | RITM | $2.3M | 269,703 | -0.02pp | 11q | -34.5%-$1.2M | |
| INVESCO QQQ TR CALL | QQQ | $2.2M | options only | +0.01pp | 2q | OPTIONS | |
| DANAHER CORP DEL | DHR | $2.1M | 9,505 | -0.08pp | 11q | -77.8%-$7.4M | |
| PACIRA BIOSCIENCES INC | PCRX | $2.1M | 82,814 | flat | 8q | HELD | |
| COLLEGIUM PHARMACEUTICAL INC | COLL | $2.0M | 93,521 | - | new | NEW | |
| SIMPLIFY EXCHANGE TRADED FUN | DINE | $1.8M | 75,000 | - | new | NEW | |
| PHATHOM PHARMACEUTICALS INC | PHAT | $1.8M | 249,267 | -0.01pp | 15q | HELD | |
| EDWARDS LIFESCIENCES CORP | EW | $1.6M | 18,617 | flat | 8q | HELD | |
| INSMED INC | INSM | $1.6M | 13,898 | flat | 8q | -2.1%-$33.3K | |
| ABEONA THERAPEUTICS INC | ABEO | $1.5M | 276,333 | -0.01pp | 10q | -20.0%-$362.7K | |
| ORCHESTRA BIOMED HLDGS INC | OBIO | $1.4M | 219,387 | +0.01pp | 3q | HELD | |
| AQUESTIVE THERAPEUTICS INC | AQST | $1.3M | 278,723 | flat | 3q | HELD | |
| KYVERNA THERAPEUTICS INC | KYTX | $1.2M | 182,603 | flat | 4q | HELD | |
| TG THERAPEUTICS INC | TGTX | $1.2M | 21,211 | flat | 8q | HELD | |
| INVENTIVA SA | IVA | $1.2M | 313,483 | flat | 4q | HELD | |
| COMPASS PATHWAYS PLC | CMPS | $1.1M | 90,381 | flat | 5q | -20.9%-$297.3K | |
| BRAEMAR HOTELS & RESORTS INC | BHR | $1.1M | 653,000 | +0.01pp | 2q | +256.8%+$784.9K | |
| CABALETTA BIO INC | CABA | $1.1M | 556,235 | - | new | NEW | |
| FULL HSE RESORTS INC | FLL | $862.6K | 607,500 | flat | 2q | +53.0%+$298.9K | |
| PROKIDNEY CORP | PROK | $803.0K | 483,741 | - | new | NEW | |
| PALANTIR TECHNOLOGIES INC | PLTR | $788.8K | 4,217 | -0.01pp | 5q | -64.9%-$1.5M | |
| COOPER COS INC | COO | $743.1K | 13,146 | flat | 11q | HELD | |
| ARTIVA BIOTHERAPEUTICS INC | ARTV | $721.6K | 101,355 | flat | 3q | HELD | |
| CELLDEX THERAPEUTICS INC NEW | CLDX | $701.0K | 21,629 | -0.02pp | 5q | -59.3%-$1.0M | |
| CISCO SYS INC | CSCO | $698.9K | 6,494 | -0.02pp | 5q | -61.6%-$1.1M | |
| AGILON HEALTH INC | AGL | $669.0K | 8,406 | flat | 2q | HELD | |
| WALMART INC | WMT | $660.5K | 6,356 | -0.02pp | 5q | -62.4%-$1.1M | |
| OCULAR THERAPEUTIX INC | OCUL | $621.7K | 81,051 | flat | 3q | HELD | |
| STRYKER CORPORATION | SYK | $618.0K | 2,244 | flat | 19q | HELD | |
| PALISADE BIO INC COM | PALI | $586.4K | 434,333 | flat | 3q | -3.6%-$21.9K | |
| DYNEX CAP INC | DX | $567.2K | 50,914 | -0.02pp | 4q | -62.1%-$931.1K | |
| FULCRUM THERAPEUTICS INC | FULC | $567.2K | 153,290 | flat | 15q | HELD | |
| DELL TECHNOLOGIES INC | DELL | $551.9K | 1,026 | -0.01pp | 5q | -67.7%-$1.2M | |
| ARMOUR RESIDENTIAL REIT INC | ARR | $551.1K | 39,851 | flat | 4q | -26.1%-$194.3K | |
| LEONABIO INC | LONA | $532.9K | 149,279 | -0.01pp | 5q | HELD | |
| ANNALY CAPITAL MANAGEMENT IN | NLY | $518.5K | 27,447 | -0.01pp | 13q | -61.8%-$838.6K | |
| MFA FINL INC | MFA | $516.3K | 65,773 | -0.01pp | 4q | -60.8%-$800.5K | |
| BERKSHIRE HATHAWAY INC DEL | BRKB | $486.5K | 977 | -0.01pp | 3q | -63.3%-$839.0K | |
| NEUROCRINE BIOSCIENCES INC | NBIX | $468.9K | 3,306 | flat | 7q | HELD | |
| SIMPLIFY EXCHANGE TRADED FUN | TUA | $452.0K | 23,740 | -1.36pp | 3q | -99.5%-$91.1M | |
| AGNC INVT CORP | AGNC | $431.8K | 47,602 | -0.01pp | 13q | -58.8%-$615.7K | |
| CROWDSTRIKE HLDGS INC | CRWD | $406.4K | 1,535 | - | new | NEW | |
| ZIMMER BIOMET HOLDINGS INC | ZBH | $389.3K | 4,383 | flat | 5q | HELD | |
| PENNYMAC MTG INVT TR | PMT | $374.3K | 47,500 | flat | 2q | -11.2%-$47.3K | |
| SEAGATE TECHNOLOGY HLDNGS PL | STX | $363.4K | 394 | -0.01pp | 4q | -60.2%-$549.7K | |
| ABBOTT LABORATORIES | ABT | $334.7K | 3,387 | -0.02pp | 20q | -83.5%-$1.7M | |
| SAB BIOTHERAPEUTICS INC | SABS | $332.4K | 104,849 | flat | 4q | HELD | |
| UPSTREAM BIO INC | UPB | $327.3K | 62,113 | flat | 3q | HELD | |
| INTERNATIONAL BUSINESS MACHS | IBM | $326.4K | 1,484 | -0.01pp | 5q | -70.4%-$776.4K | |
| SALESFORCE INC | CRM | $324.6K | 1,414 | flat | 2q | -68.0%-$690.1K | |
| MASTERCARD INCORPORATED | MA | $297.8K | 540 | -0.01pp | 5q | -65.8%-$571.9K | |
| FLUOR CORP | FLR | $297.6K | 6,216 | flat | 4q | HELD | |
| WESTERN DIGITAL CORP | WDC | $295.4K | 650 | -0.01pp | 4q | -55.4%-$367.7K | |
| QUALCOMM INC | QCOM | $289.5K | 1,573 | -0.01pp | 5q | -71.2%-$717.4K | |
| CORVUS PHARMACEUTICALS INC | CRVS | $288.0K | 25,000 | - | new | NEW | |
| EXXONMOBIL HOLDINGS CORP | XOM | $286.4K | 1,760 | - | new | NEW | |
| IMMUNIC INC | IMUX | $285.7K | 30,725 | flat | 2q | HELD | |
| ICON PUB LTD CO | ICLR | $254.1K | 1,495 | flat | 2q | HELD | |
| SERVICENOW INC | NOW | $236.1K | 1,762 | flat | 5q | -68.4%-$510.4K | |
| SNOWFLAKE INC | SNOW | $217.7K | 641 | flat | 3q | -61.4%-$346.7K | |
| GE AEROSPACE | GE | $203.3K | 651 | -0.01pp | 5q | -60.4%-$309.8K | |
| 3-D SYS CORP DEL | DDD | $38.0K | 10,546 | flat | 2q | -4.2%-$1.7K |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Capital Markets | $241.4M | 4.0% |
| Biotech & Pharma | $220.9M | 3.6% |
| Other sectors | $201.7M | 3.3% |
| Not classified | $5.4B | 89.1% |
What the disclosed book did
This is not the fund's return. A 13F shows long US equity positions only, so shorts, bonds, foreign listings, private holdings and cash are all invisible here. What this measures is the quarter's change in value of the positions this manager disclosed, had they been left untouched - the return a reader following the filing would have earned.
| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +2.3% | +14.8% | -12.5% | 99% |
| Q1 2026 | -1.2% | -4.6% | +3.4% | 99% |
| Q4 2025 | -0.1% | +2.4% | -2.5% | 98% |
| Q3 2025 | +4.4% | +7.8% | -3.4% | 98% |
| Q2 2025 | +6.6% | +10.5% | -3.9% | 100% |
| Q1 2025 | -1.8% | -4.6% | +2.7% | 100% |
| Q4 2024 | -4.2% | +2.1% | -6.4% | 100% |
| Q3 2024 | +5.0% | +5.4% | -0.5% | 100% |
Market is SPY over the same two quarter ends, priced the same way as everything else here - the median across every filer reporting it. It is a large-cap US proxy, so a manager holding small caps or biotech will beat or trail it for reasons that are not skill. Prices are quarter-end to quarter-end and say nothing about the path in between, or about trades opened and closed inside a quarter.
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | $6.1B | 113 | 13 | 10 | 51 | 39 | 92.3% | 27 |
| Q2 2026 | $7.2B | 139 | 20 | 69 | 36 | 23 | 91.9% | 16 |
| Q1 2026 | $6.5B | 142 | 35 | 22 | 70 | 34 | 94.2% | 27 |
| Q4 2025 | $6.1B | 141 | 37 | 74 | 17 | 24 | 92.9% | 40 |
| Q3 2025 | $5.4B | 128 | 49 | 43 | 22 | 10 | 94.2% | 20 |
| Q2 2025 | $2.0B | 89 | 17 | 16 | 49 | 22 | 88.2% | 38 |
| Q1 2025 | $2.7B | 94 | 16 | 36 | 24 | 14 | 90.2% | 43 |
| Q4 2024 | $2.0B | 92 | 24 | 18 | 32 | 37 | 86.9% | 42 |
| Q3 2024 | $2.1B | 105 | 20 | 47 | 19 | 22 | 79.6% | 43 |
| Q2 2024 | $1.5B | 107 | 29 | 16 | 30 | 23 | 76.9% | 43 |
| Q1 2024 | $1.7B | 101 | 29 | 31 | 15 | 38 | 84.4% | 43 |
| Q4 2023 | $1.1B | 110 | 21 | 18 | 43 | 29 | 84.6% | 43 |
| Q3 2023 | $874.7M | 118 | 21 | 28 | 42 | 14 | 75.4% | 45 |
| Q2 2023 | $759.5M | 111 | 20 | 40 | 24 | 23 | 74.6% | 45 |
| Q1 2023 | $697.0M | 114 | 60 | 22 | 29 | 20 | 74.7% | 40 |
| Q4 2022 | $648.9M | 74 | 12 | 38 | 20 | 5 | 86.4% | 41 |
| Q3 2022 | $941.3M | 67 | 10 | 43 | 12 | 9 | 90.0% | 45 |
| Q2 2022 | $2.6B | 66 | 10 | 29 | 22 | 29 | 97.2% | 42 |
| Q1 2022 | $3.1B | 85 | 33 | 33 | 12 | 15 | 97.1% | 43 |
| Q4 2021 | $2.3B | 67 | 41 | 21 | 2 | 4 | 98.7% | 45 |
| Q3 2021 | $1.4B | 30 | 17 | 6 | 5 | 2 | 99.4% | 43 |
| Q2 2021 | $667.1M | 15 | 5 | 6 | 3 | 0 | 99.7% | 44 |
| Q1 2021 | $248.8M | 10 | 0 | 7 | 1 | 21 | 100.0% | 47 |
| Q4 2020 | $109.8M | 31 | 0 | 0 | 0 | 0 | 99.0% | 47 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.